TG Therapeutics | TGTX - 借入資本

株価
33.79
毎日の変更
0.06 0.18%
毎月
17.45%
毎年
-12.03%
Q2 予測
32.81




借入資本 変化する 日付
AbbVie USD 62.97B 12M 2025-09
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Amgen USD 50B 2.43B 2025-12
Ardelyx USD 202.83M 696K 2025-12
Arrowhead Research USD 538.1M 323.22M 2025-12
Bayer EUR 31.83B 877M 2025-12
Biogen USD 6.29B 1.4M 2025-09
Curis USD 29.43M 10.69M 2024-06
Gilead Sciences USD 22.14B 5M 2025-09
Infinity Pharmaceuticals USD 0 0 2022-06
J&J USD 39.44B 30M 2025-12
Karyopharm Therapeutics USD 278.22M 278.22M 2025-12
Novartis USD 29.59B 5.35B 2025-12
Novavax USD 246.3M 200K 2025-12
PTC Therapeutics USD 2.03B 193.22M 2025-12
Puma Biotechnology USD 10.87M 222K 2025-06
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
TG Therapeutics USD 245.64M 305K 2025-12
Verastem USD 81.33M 31.01M 2025-12
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03